tetracycline

(redirected from Tetracyclin)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Tetracyclin: Tetracycline antibiotics

tet·ra·cy·cline

 (tĕt′rə-sī′klēn′, -klĭn)
n.
1. A yellow crystalline compound, C22H24N2O8, synthesized or derived from certain microorganisms of the genus Streptomyces and used as a broad-spectrum antibiotic.
2. An antibiotic, such as chlortetracycline and oxytetracycline, having the same basic structure.

tetracycline

(ˌtɛtrəˈsaɪklaɪn; -klɪn)
n
(Pharmacology) an antibiotic synthesized from chlortetracycline or derived from the bacterium Streptomyces viridifaciens: used in treating rickettsial infections and various bacterial infections. Formula: C22H24N2O8
[C20: from tetra- + cycl(ic) + -ine2]

tet•ra•cy•cline

(ˌtɛ trəˈsaɪ klin, -klɪn)

n.
an antibiotic, C22H24H2O8, derived from a streptomyces, used in medicine to treat a broad variety of infections.
[1952; tetracycl(ic) having four fused hydrocarbon rings]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.tetracycline - an antibiotic (trade name Achromycin) derived from microorganisms of the genus Streptomyces and used broadly to treat infectionstetracycline - an antibiotic (trade name Achromycin) derived from microorganisms of the genus Streptomyces and used broadly to treat infections
antibacterial, antibacterial drug, bactericide - any drug that destroys bacteria or inhibits their growth
Declomycin, demeclocycline hydrochloride - tetracycline antibacterial (trade name Declomycin) effective in the treatment of some bacterial and rickettsial and other infections
Minocin, minocycline - tetracycline antibiotic (trade name Minocin) used to treat a variety of bacterial and rickettsial infections
Translations

tet·ra·cy·cline

n. tetraciclina, antibiótico de espectro amplio usado para combatir microorganismos gram-positivos y gram-negativos, ricketsia y cierta variedad de virus.

tetracycline

n tetraciclina
References in periodicals archive ?
Bacterial cells were grown on media containing rifampicin (50mg/L), spectinomycin (100mg/L) and tetracyclin (2mg/L).
Three months of treatment with tetracyclin costs [euro]108 (111), and a combination treatment of rifampicin and clindamycin costs [euro]266 (112,113).
Table 1 The detailed characteristics of plasmids used in the present study Plasmid Proteins Drug resistance marker pUC57 hscFv-antiCD20 Amp pET22b(+) hscFv-antiCD20 Amp pG-KJE8 dnaK-dnaJ-grpE-groES-groEL Cm pGro7 groES-groEL I'm pKjE7 DnaK-dnaJ-grpE Cm pTf16 groES-groEL-tig Cm pG-Tf2 tig Cm Plasmid Promoter Inducer Reference pUC57 lac IPTG [15] pET22b(+) T7 IPTG This study pG-KJE8 araB L-Arabinose Pztl Tetracyclin (Takara.
The Gram-positive biofilm producers, 3 of 3 bacterial isolates, were resistance to amoxicillin-clavulanate, tetracyclin, and cloxacillin; nonetheless, the antibiotics--vancomycin, fosfomycin, meropenem, and piperacillin/tazobactam--were found to be effective even for the biofilm producers (Table 3).
Tetracyclin and chloramphenicol efficacy against selected biofilm forming bacteria.
Moreover, 72.7%, 69.6%, 57.5%, 54.5%, 51.5 the Shigella flexneri isolates were resistant to Amikacin, Amoxicillin and Tobramycin, Nalidixic acid, Cefepime, Ciprofloxacin and Tetracyclin, respectively (Figure1).
[B.sub.12], 0.0015; niacin, 3.0 g; calcium-D-pantothenate, 1.5 g; biotin, 0.010 g; folic acid, 0.20 g; vit-K, 0.4 g; Dicalcium phosphate, 2,000g; salt, 400 g herbal liver stimulant, 170 g; semduramicin, 3.0 g; tetracyclin, 3.0 g; toxin binder, 200 g.
ANTIBIOTICS Percentage of bacteria MSSA MRSA Ciprofloxacin 9.61 75.86 Levofloxacin 0.87 19.30 Linezolid 0.00 0.58 Teicoplanin 0.00 0.58 Azithromycin 35.64 93.57 Co-trimoxazole 26.13 89.441 Tetracyclin 12.54 64.29 Gentamycin 14.36 89.47 Lincomycin 24.91 85.38 Note: Table made from bar graph.
CONS found to be 100% sensitive to vancomycin, tetracyclin, linezolid and 100% resistant to erythromycin.
Blank disc impregnated with DMSO was used as negative control and Tetracyclin was taken as positive control.
The results indicated that resistance rate of antibiotics was in the range of 95% Penicillin (PEN), 82% Amoxicillin (AMO), 77% Cefazolin (CEF), 59% Ceftriaxone (CEFT) and Tetracyclin (TET), 46% Gentamicin (GEN), 32% Nitrofurantoin (NIT), 27% Cefoxitin (CEFX and Ofloxacin (OFL), 23% Streptomycin (STR), 19% Chloramfenicol (CHL) and 9% Meropenem (MER).
And the rise of drug-resistant bacteria is not only fostered by the direct use, or misuse, of antibiotics in hospitals or for individual therapy; nowadays, bacteria also mutate in animal environments through the widespread practice of adding penicillin and tetracyclin to animal feed to improve the growth rate of healthy animals, to reduce the amount of feed used in their diet, for animal treatment during illness, and to curb recurrent infectious outbreaks caused by livestock living in cramped and unsanitary situations.